The European Parliament has approved the new Horizon Europe research and innovation programme.

It will run from 2021 to 2027 with big changes including quicker and easier access to EU funding, especially for innovative SMEs, incentives for EU countries lagging behind in research and innovation to take part in the programme, and 35% of the budget being earmarked for projects combating climate change.

And thanks largely to the EPP Group, paediatric cancer is, for the first time, explicitly mentioned as a research priority.

Other related content